{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T14:06:21Z","timestamp":1776434781875,"version":"3.51.2"},"reference-count":85,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"NIDA","award":["R01 DA002925"],"award-info":[{"award-number":["R01 DA002925"]}]},{"DOI":"10.13039\/100000025","name":"NIMH","doi-asserted-by":"crossref","award":["K01 MH100644"],"award-info":[{"award-number":["K01 MH100644"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Veteran's Affairs","award":["VISN 22 MIRECC"],"award-info":[{"award-number":["VISN 22 MIRECC"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology Biochemistry and Behavior"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.pbb.2016.05.009","type":"journal-article","created":{"date-parts":[[2016,5,27]],"date-time":"2016-05-27T04:48:43Z","timestamp":1464324523000},"page":"69-75","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Effects of the psychotomimetic benzomorphan N -allylnormetazocine (SKF 10,047) on prepulse inhibition of startle in mice"],"prefix":"10.1016","volume":"148","author":[{"given":"Adam L.","family":"Halberstadt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Hyun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael A.","family":"Ruderman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan B.","family":"Powell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pbb.2016.05.009_bb0005","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s00213-011-2470-6","article-title":"Acute and post-acute behavioral and psychological effects of salvinorin A in humans","volume":"220","author":"Addy","year":"2012","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2016.05.009_bb0010","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1126\/science.137.3529.541","article-title":"Narcotic antagonists as analgesics","volume":"137","author":"Archer","year":"1962","journal-title":"Science"},{"key":"10.1016\/j.pbb.2016.05.009_bb0020","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/S0022-3565(24)38001-2","article-title":"Disruption of prepulse inhibition and increases in locomotor activity by competitive N-methyl-d-aspartate receptor antagonists in rats","volume":"288","author":"Bakshi","year":"1999","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pbb.2016.05.009_bb0025","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/S0022-3565(25)23493-0","article-title":"Substitution and antagonism in rats trained to discriminate (+)-N-allylnormetazocine from saline","volume":"249","author":"Balster","year":"1989","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pbb.2016.05.009_bb0030","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1002\/j.1552-4604.1977.tb05640.x","article-title":"Twin crossover relative potency analgesic assays in man. II. Morphine vs. 8-methoxycyclazocine","volume":"17","author":"Beaver","year":"1977","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.pbb.2016.05.009_bb0035","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1016\/j.biopsych.2005.02.030","article-title":"Kappa opioid receptor activation disrupts prepulse inhibition of the acoustic startle in rats","volume":"57","author":"Bortolato","year":"2005","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pbb.2016.05.009_bb0040","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1126\/science.6274022","article-title":"Stereoisomers of N-allylnormetazocine: phencyclidine-like behavioral effects in squirrel monkeys and rats","volume":"215","author":"Brady","year":"1982","journal-title":"Science"},{"key":"10.1016\/j.pbb.2016.05.009_bb0045","doi-asserted-by":"crossref","first-page":"2812","DOI":"10.1021\/jm00093a014","article-title":"Enantiomeric N-substituted N-normetazocines: a comparative study of affinities at sigma, PCP, and mu opioid receptors","volume":"35","author":"Carroll","year":"1992","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.pbb.2016.05.009_bb0050","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/0014-2999(95)00552-8","article-title":"(\u2212)-Pentazocine analgesia in mice: interactions with a \u03c3 receptor system","volume":"294","author":"Chien","year":"1995","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pbb.2016.05.009_bb0055","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/S0022-3565(25)38166-8","article-title":"NPC 16377, a potent and selective \u03c3-ligand, II: behavioral and neuroprotective profile","volume":"265","author":"Clissold","year":"1993","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pbb.2016.05.009_bb0060","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1177\/106002807801200602","article-title":"The psychotomimetic side effects of pentazocine","volume":"12","author":"Coursey","year":"1978","journal-title":"Drug Intelligence Clin Pharmacol"},{"key":"10.1016\/j.pbb.2016.05.009_bb0065","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0278-5846(97)00184-X","article-title":"Effects of phencyclidine (PCP) and (+)-MK801 on sensorimotor gating in CD-1 mice","volume":"22","author":"Curzon","year":"1998","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.pbb.2016.05.009_bb0070","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0014-5793(89)81427-9","article-title":"Synthesis and evaluation of optically pure [3H]-(+)-pentazocine, a highly potent and selective radioligand for sigma receptors","volume":"251","author":"De Costa","year":"1989","journal-title":"FEBS Lett."},{"key":"10.1016\/j.pbb.2016.05.009_bb0080","series-title":"Sigma and Phencyclidine-like Compounds as Molecular Probes in Biology","first-page":"315","article-title":"Pharmacological studies suggest that sigma receptors labeled in vivo with [3H]-(+)-SKF 10,047 are predominantly of the high affinity type","author":"Ferris","year":"1988"},{"key":"10.1016\/j.pbb.2016.05.009_bb0085","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1002\/cpt1969104468","article-title":"Analgesic and other effects of the d- and l-isomers of penzocine","volume":"10","author":"Forrest","year":"1969","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.pbb.2016.05.009_bb0090","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s002130050369","article-title":"Dizocilpine-like discriminative stimulus effects of competitive NMDA receptor antagonists in mice","volume":"133","author":"Geter-Douglass","year":"1997","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2016.05.009_bb0095","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/0014-5793(85)81313-2","article-title":"Differentiation of [3H]phencyclidine and (+)-[3H]SKF-10,047 binding sites in rat cerebral cortex","volume":"190","author":"Goldman","year":"1985","journal-title":"FEBS Lett."},{"key":"10.1016\/j.pbb.2016.05.009_bb0100","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/BF00310511","article-title":"Evidence for multiple opiate receptor involvement in different phencyclidine-induced unconditioned behaviors in rats","volume":"88","author":"Greenberg","year":"1986","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2016.05.009_bb0105","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1007\/BF00402763","article-title":"Subjective effects of narcotic antagonists cyclazocine and nalorphine on the Addiction Research Center Inventory (ARCI)","volume":"18","author":"Haertzen","year":"1970","journal-title":"Psychopharmacologia"},{"key":"10.1016\/j.pbb.2016.05.009_bb0110","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s00213-009-1718-x","article-title":"LSD but not lisuride disrupts prepulse inhibition in rats by activating the 5-HT2A receptor","volume":"208","author":"Halberstadt","year":"2010","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2016.05.009_bb0115","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1007\/s00213-016-4203-3","article-title":"The novel ketamine analog methoxetamine produces dissociative-like behavioral effects in rodents","volume":"233","author":"Halberstadt","year":"2016","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2016.05.009_bb0120","doi-asserted-by":"crossref","first-page":"8072","DOI":"10.1073\/pnas.93.15.8072","article-title":"Purification, molecular cloning, and expression of the mammalian sigma1-binding site","volume":"93","author":"Hanner","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.pbb.2016.05.009_bb0125","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1038\/sj.npp.1301047","article-title":"Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of fluvoxamine: role of sigma-1 receptors","volume":"32","author":"Hashimoto","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pbb.2016.05.009_bb0130","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1073\/pnas.98.2.491","article-title":"Regulating ankyrin dynamics: roles of sigma-1 receptors","volume":"98","author":"Hayashi","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.pbb.2016.05.009_bb0140","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.brainres.2005.07.028","article-title":"Improvement of memory impairment by (+)- and (\u2212)-pentazocine via sigma, but not kappa opioid receptors","volume":"1057","author":"Hiramatsu","year":"2005","journal-title":"Brain Res."},{"key":"10.1016\/j.pbb.2016.05.009_bb0145","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/0091-3057(93)90473-7","article-title":"Discriminative stimulus effects of the PCP\/sigma-ligand (+)-N-allylnormetazocine in monkeys","volume":"44","author":"Holtzman","year":"1993","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pbb.2016.05.009_bb0150","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1097\/00000542-195501000-00010","article-title":"Some effects of N-allylnormorphine on normal subjects and a review of the literature","volume":"16","author":"Huggins","year":"1955","journal-title":"Anesthesiology"},{"key":"10.1016\/j.pbb.2016.05.009_bb0155","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/S0026-895X(25)11457-0","article-title":"Characterization of specific binding sites for [3H](d)-N-allylnormetazocine in rat brain membranes","volume":"27","author":"Itzhak","year":"1985","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.pbb.2016.05.009_bb0160","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/BF00310633","article-title":"Comparison of the pharmacologic effects of N-allylnormetazocine and phencyclidine: sensitization, cross-sensitization, and opioid antagonist activity","volume":"89","author":"Iwamoto","year":"1986","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2016.05.009_bb0165","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1136\/jramc-130-01-10","article-title":"The effect of naloxone on pentazocine induced hallucinations","volume":"130","author":"Jago","year":"1984","journal-title":"J. R. Army Med. Corps"},{"key":"10.1016\/j.pbb.2016.05.009_bb0170","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/cpt196892215","article-title":"Antagonism of the subjective, behavioral, pupillary, and respiratory depressant effects of cyclazocine by naloxone","volume":"9","author":"Jasinski","year":"1968","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.pbb.2016.05.009_bb0175","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1176\/ajp.148.10.1301","article-title":"Recent advances in the phencyclidine model of schizophrenia","volume":"148","author":"Javitt","year":"1991","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.pbb.2016.05.009_bb0180","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.drugalcdep.2010.11.005","article-title":"Human psychopharmacology and dose-effects of salvinorin A, a kappa opioid agonist hallucinogen present in the plant Salvia divinorum","volume":"115","author":"Johnson","year":"2011","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.pbb.2016.05.009_bb0185","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/S0022-3565(25)11881-8","article-title":"Subjective effects of nalorphine in hospitalized patients","volume":"119","author":"Keats","year":"1957","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pbb.2016.05.009_bb0190","series-title":"Molecular Modification in Drug Design","first-page":"170","article-title":"Narcotic antagonists as analgesics: clinical aspects","volume":"vol. 45","author":"Keats","year":"1964"},{"issue":"3","key":"10.1016\/j.pbb.2016.05.009_bb0195","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/S0022-3565(25)24372-5","article-title":"Human psychopharmacology of ketocyclazocine as compared with cyclazocine, morphine and placebo","volume":"238","author":"Kumor","year":"1986","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pbb.2016.05.009_bb0200","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S0022-3565(25)24925-4","article-title":"Pharmacological and autoradiographic discrimination of sigma and phencyclidine receptor binding sites in brain with (+)-[3H]SKF 10,047, (+)-[3H]-3-[3-hydroxyphenyl]-N-(1-propyl)piperidine and [3H]-1-[1-(2-thienyl)cyclohexyl]piperidine","volume":"238","author":"Largent","year":"1986","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pbb.2016.05.009_bb0205","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1001\/archinte.1954.00250040024004","article-title":"Nalorphine (N-allylnormorphine): practical and theoretical considerations","volume":"94","author":"Lasagna","year":"1954","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.pbb.2016.05.009_bb0210","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/S0022-3565(25)11395-5","article-title":"The analgesic effectiveness of nalorphine and nalorphine-morphine combinations in man","volume":"112","author":"Lasagna","year":"1954","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pbb.2016.05.009_bb0215","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/S0022-3565(25)26750-7","article-title":"The analgesic efficacy and respiratory effects in man of a benzomorphan \u201cnarcotic antagonist\u201d","volume":"144","author":"Lasagna","year":"1964","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pbb.2016.05.009_bb0220","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S0022-3565(25)10377-7","article-title":"Tolerance to the cataleptic effect of the N-methyl-d-aspartate (NMDA) receptor antagonists in pigeons: cross-tolerance between PCP-like compounds and competitive NMDA antagonists","volume":"263","author":"Lu","year":"1992","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pbb.2016.05.009_bb0225","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s00213-012-2912-9","article-title":"Dose-related effects of salvinorin A in humans: dissociative, hallucinogenic, and memory effects","volume":"226","author":"MacLean","year":"2013","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2016.05.009_bb0230","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/0893-133X(89)90035-3","article-title":"Effects of phencyclidine and phencyclidine biologs on sensorimotor gating in the rat","volume":"2","author":"Mansbach","year":"1989","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pbb.2016.05.009_bb0235","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1007\/BF02244303","article-title":"Parametric determinants in pre-stimulus modification of acoustic startle: interaction with ketamine","volume":"105","author":"Mansbach","year":"1991","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pbb.2016.05.009_bb0240","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/BF00212846","article-title":"Dopaminergic stimulation disrupts sensorimotor gating in the rat","volume":"94","author":"Mansbach","year":"1988","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2016.05.009_bb0245","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0022-3565(25)30536-7","article-title":"The effects of morphine- and nalorphine-like drugs in the nondependent and morphine-dependent chronic spinal dog","volume":"197","author":"Martin","year":"1976","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pbb.2016.05.009_bb0250","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/jnr.490260315","article-title":"In vivo labeling of phencyclidine (PCP) receptors with 3H-TCP in the mouse brain","volume":"26","author":"Maurice","year":"1990","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.pbb.2016.05.009_bb0255","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/S0022-3565(25)13262-X","article-title":"Structure-activity relationships of arylcyclohexylamines as discriminative stimuli in pigeons","volume":"247","author":"McMillan","year":"1988","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pbb.2016.05.009_bb0260","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0006-2952(01)00666-9","article-title":"Molecular cloning and pharmacological characterization of the rat sigma1 receptor","volume":"62","author":"Mei","year":"2001","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.pbb.2016.05.009_bb0265","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S0022-3565(25)22867-1","article-title":"Sigma opioid receptor: characterization and co-identity with the phencyclidine receptor","volume":"233","author":"Mendelsohn","year":"1985","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pbb.2016.05.009_bb0270","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1021\/jm00198a009","article-title":"N-[(Tetrahydrofuryl)alkyl] and N-(alkoxyalkyl) derivatives of (\u2212)-normetazocine, compounds with differentiated opioid action profiles","volume":"22","author":"Merz","year":"1979","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.pbb.2016.05.009_bb0275","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1471-2210-12-5","article-title":"Long-acting \u03ba opioid antagonists nor-BNI, GNTI and JDTic: pharmacokinetics in mice and lipophilicity","volume":"12","author":"Munro","year":"2012","journal-title":"BMC Pharmacol."},{"key":"10.1016\/j.pbb.2016.05.009_bb0280","first-page":"191","article-title":"The psychotomimetic effects of opiates and the sigma receptor","volume":"3","author":"Musacchio","year":"1990","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pbb.2016.05.009_bb0285","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0014-2999(96)00254-3","article-title":"Interactions of selective serotonin reuptake inhibitors with subtypes of sigma receptors in rat brain","volume":"307","author":"Narita","year":"1996","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pbb.2016.05.009_bb0290","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/S0022-3565(25)12708-0","article-title":"Affinity of drugs and peptides for U-69,593-sensitive and -insensitive kappa opiate binding sites: the U-69,593-insensitive site appears to be the beta endorphin-specific epsilon receptor","volume":"254","author":"Nock","year":"1990","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pbb.2016.05.009_bb0295","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1124\/jpet.113.206086","article-title":"Physical presence of nor-binaltorphimine in mouse brain over 21days after a single administration corresponds to its long-lasting antagonistic effect on \u03ba-opioid receptors","volume":"346","author":"Patkar","year":"2013","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pbb.2016.05.009_bb0300","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1126\/science.3016896","article-title":"Psychotomimesis mediated by kappa opiate receptors","volume":"233","author":"Pfeiffer","year":"1986","journal-title":"Science"},{"key":"10.1016\/j.pbb.2016.05.009_bb0305","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.biopsych.2012.06.012","article-title":"Dose-related behavioral, subjective, endocrine, and psychophysiological effects of the \u03ba opioid agonist salvinorin A in humans","volume":"72","author":"Ranganathan","year":"2012","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pbb.2016.05.009_bb0310","doi-asserted-by":"crossref","first-page":"3069","DOI":"10.1097\/00001756-199809140-00028","article-title":"Sigma (sigma1) receptor mediated anti-depressant-like effects of neurosteroids in the Porsolt forced swim test","volume":"9","author":"Reddy","year":"1998","journal-title":"Neuroreport"},{"key":"10.1016\/j.pbb.2016.05.009_bb0315","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1177\/026988118900300402","article-title":"The discriminative stimulus effects of MK-801: generalization to other N-methyl-d-aspartate receptor antagonists","volume":"3","author":"Sanger","year":"1989","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.pbb.2016.05.009_bb9100","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.biopsych.2014.11.015","article-title":"Acute effects of lysergic acid diethylamide in healthy subjects","volume":"78","author":"Schmid","year":"2016","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pbb.2016.05.009_bb0320","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1006\/bbrc.1997.7840","article-title":"Cloning and structural analysis of the cDNA and the gene encoding the murine type 1 sigma receptor","volume":"241","author":"Seth","year":"1997","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.pbb.2016.05.009_bb0325","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/0014-2999(82)90207-2","article-title":"Phencyclidine-like discriminative stimuli of (+)- and (\u2212)-N-allylnormetazocine in rats","volume":"84","author":"Shannon","year":"1982","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pbb.2016.05.009_bb0330","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0014-2999(82)90506-4","article-title":"Non-opioid psychotomimetic-like discriminative stimulus properties of N-allylnormetazocine (SKF 10,047) in the rat","volume":"82","author":"Shearman","year":"1982","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pbb.2016.05.009_bb0335","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1476-5381.1990.tb14668.x","article-title":"Evidence against an involvement of the haloperidol-sensitive sigma recognition site in the discriminative stimulus properties of (+)-N-allylnormetazocine ((+)-SKF 10,047)","volume":"99","author":"Singh","year":"1990","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.pbb.2016.05.009_bb0340","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/0024-3205(87)90135-4","article-title":"Discriminative stimulus effects of N-allylnormetazocine in rats trained to discriminate a kappa from a sigma agonist","volume":"40","author":"Slifer","year":"1987","journal-title":"Life Sci."},{"key":"10.1016\/j.pbb.2016.05.009_bb0345","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0376-8716(83)90039-X","article-title":"Effects of SKF-10047 in the phencyclidine-dependent rat: evidence for common receptor mechanisms","volume":"12","author":"Stafford","year":"1983","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.pbb.2016.05.009_bb0350","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/S0022-3565(25)33330-6","article-title":"Evidence for sigma opioid receptor: binding of [3H]SKF-10047 to etorphine-inaccessible sites in guinea-pig brain","volume":"223","author":"Su","year":"1982","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pbb.2016.05.009_bb0355","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.2174\/0929867033456783","article-title":"Understanding the molecular mechanism of sigma-1 receptors: towards a hypothesis that sigma-1 receptors are intracellular amplifiers for signal transduction","volume":"10","author":"Su","year":"2003","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.pbb.2016.05.009_bb0360","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1126\/science.2832949","article-title":"Steroid binding at sigma receptors suggests a link between endocrine, nervous, and immune systems","volume":"240","author":"Su","year":"1988","journal-title":"Science"},{"key":"10.1016\/j.pbb.2016.05.009_bb0365","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0022-3565(25)21011-4","article-title":"Nor-binaltorphimine, a highly selective kappa-opioid antagonist in analgesic and receptor binding assays","volume":"246","author":"Takemori","year":"1988","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pbb.2016.05.009_bb0370","doi-asserted-by":"crossref","first-page":"6703","DOI":"10.1073\/pnas.80.21.6703","article-title":"Naloxone-inaccessible sigma receptor in rat central nervous system","volume":"80","author":"Tam","year":"1983","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.pbb.2016.05.009_bb0375","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0014-2999(85)90536-9","article-title":"(+)-[3H]SKF 10,047, (+)-[3H]ethylketocyclazocine, \u03bc, \u03ba, \u03b4 and phencyclidine binding sites in guinea pig brain membranes","volume":"109","author":"Tam","year":"1985","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pbb.2016.05.009_bb0380","doi-asserted-by":"crossref","first-page":"5618","DOI":"10.1073\/pnas.81.17.5618","article-title":"Sigma opiates and certain antipsychotic drugs mutually inhibit (+)-[3H]SKF 10,047 and [3H]haloperidol binding in guinea pig brain membranes","volume":"81","author":"Tam","year":"1984","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.pbb.2016.05.009_bb0385","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/S0022-3565(25)22016-X","article-title":"Discriminative stimulus properties of nalorphine in the rhesus monkeys","volume":"227","author":"Tang","year":"1983","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pbb.2016.05.009_bb0390","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s00213-010-1799-6","article-title":"The effects of kappa-opioid receptor ligands on prepulse inhibition and CRF-induced prepulse inhibition deficits in the rat","volume":"210","author":"Tejeda","year":"2010","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2016.05.009_bb0395","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/S0361-9230(01)00646-3","article-title":"A systems model of altered consciousness: integrating natural and drug-induced psychoses","volume":"56","author":"Vollenweider","year":"2001","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.pbb.2016.05.009_bb9000","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0157021","article-title":"Pharmacological investigations of the dissociative \u2018legal highs\u2019 diphenidine, methoxphenidine and analogues","author":"Wallach","year":"2016","journal-title":"PLOS One"},{"key":"10.1016\/j.pbb.2016.05.009_bb0400","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s002130100788","article-title":"Enadoline, a selective kappa opioid agonist: comparison with butorphanol and hydromorphone in humans","volume":"157","author":"Walsh","year":"2001","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2016.05.009_bb0405","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S0022-3565(25)05224-3","article-title":"N-allylnormorphine: effects of single doses and precipitation of acute \u201cabstinence syndromes\u201d during addiction to morphine, methadone or heroin in man (postaddicts)","volume":"100","author":"Wikler","year":"1953","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pbb.2016.05.009_bb0410","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1007\/s00213-002-1297-6","article-title":"Affinity and specificity of N-methyl-d-aspartate channel blockers affect their ability to disrupt prepulse inhibition of acoustic startle in rats","volume":"165","author":"Wiley","year":"2003","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2016.05.009_bb0415","doi-asserted-by":"crossref","first-page":"7104","DOI":"10.1073\/pnas.83.18.7104","article-title":"The anticonvulsant MK-801 is a potent N-methyl-d-aspartate antagonist","volume":"83","author":"Wong","year":"1986","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.pbb.2016.05.009_bb0420","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0014-2999(00)00498-2","article-title":"Effects of \u03c31 receptor ligand, MS-377 on apomorphine- or phencyclidine-induced disruption of prepulse inhibition of acoustic startle in rats","volume":"402","author":"Yamada","year":"2000","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pbb.2016.05.009_bb0430","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/s00213-004-2087-0","article-title":"Effects of the plant-derived hallucinogen salvinorin A on basal dopamine levels in the caudate putamen and in a conditioned place aversion assay in mice: agonist actions at kappa opioid receptors","volume":"179","author":"Zhang","year":"2005","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2016.05.009_bb0435","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S0026-895X(25)14126-6","article-title":"Demonstration of [3H]cyclazocine binding to multiple opiate receptor sites","volume":"20","author":"Zukin","year":"1981","journal-title":"Mol. Pharmacol."}],"container-title":["Pharmacology Biochemistry and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305716300995?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305716300995?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T19:44:36Z","timestamp":1748979876000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091305716300995"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":85,"alternative-id":["S0091305716300995"],"URL":"https:\/\/doi.org\/10.1016\/j.pbb.2016.05.009","relation":{},"ISSN":["0091-3057"],"issn-type":[{"value":"0091-3057","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of the psychotomimetic benzomorphan N-allylnormetazocine (SKF 10,047) on prepulse inhibition of startle in mice","name":"articletitle","label":"Article Title"},{"value":"Pharmacology Biochemistry and Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pbb.2016.05.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}